يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Merelli, B."', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    دورية أكاديمية
    The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600

    المؤلفون: Massi, D., Merelli, B., Falcone, C., Xue, G., Carobbio, A., Nassini, R., Baroni, G., Tamborini, E., Cattaneo, L., Mandalã , Mario, BRUSA, Davide, AUDRITO, VALENTINA, DEAGLIO, Silvia

    المساهمون: Massi, D., Brusa, D., Merelli, B., Falcone, C., Xue, G., Carobbio, A., Nassini, R., Baroni, G., Tamborini, E., Cattaneo, L., Audrito, V., Deaglio, S., Mandalã , Mario

    مصطلحات موضوعية: BRAF inhibitor, Immune cell infiltration, Melanoma, PD-L1, Prognosi, Resistance, Adult, Aged, 80 and over, Antigens, CD274, Antineoplastic Agent, Biomarkers, Tumor, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Human, Imidazole, Indole, Lymphocyte Count, Lymphocytes, Tumor-Infiltrating, Male, Middle Aged, Oxime, Protein Kinase Inhibitor, Proto-Oncogene Proteins B-raf, Retrospective Studie

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26037795; info:eu-repo/semantics/altIdentifier/wos/WOS:000361392700027; volume:26; issue:9; firstpage:1980; lastpage:1987; numberofpages:8; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2318/1650415Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84941637917; http://annonc.oxfordjournals.orgTest/; https://www.annalsofoncology.org/article/S0923-7534Test(19)31762-4/fulltext

    الإتاحة: https://doi.org/10.1093/annonc/mdv255Test
    http://hdl.handle.net/2318/1650415Test
    http://annonc.oxfordjournals.orgTest/
    https://www.annalsofoncology.org/article/S0923-7534Test(19)31762-4/fulltext

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: A multicenter international retrospective study

    المؤلفون: Rutkowski P., Indini A., De Luca M., Merelli B., Mariuk-Jarema A., Teterycz P., Rogala P., Lugowska I., Cybulska-Stopa B., Labianca A., DI Guardo L., Del Vecchio M., Pigozzo J., Randon G., Corti F., Tondini C. A., Rulli E., Mandala' M.

    المساهمون: Rutkowski, P., Indini, A., De Luca, M., Merelli, B., Mariuk-Jarema, A., Teterycz, P., Rogala, P., Lugowska, I., Cybulska-Stopa, B., Labianca, A., DI Guardo, L., Del Vecchio, M., Pigozzo, J., Randon, G., Corti, F., Tondini, C. A., Rulli, E., Mandala', M.

    مصطلحات موضوعية: biomarkers, CTLA-4 antigen, immunotherapy, melanoma, programmed cell death 1 receptor, tumor

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33203662; info:eu-repo/semantics/altIdentifier/wos/WOS:000599997700006; volume:8; issue:2; firstpage:e001117; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; http://hdl.handle.net/11391/1481724Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85096348743

    الإتاحة: https://doi.org/10.1136/jitc-2020-001117Test
    http://hdl.handle.net/11391/1481724Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors

    المؤلفون: Laura Russo, Lorenzo Legramandi, Cristian Scatena, Cristina Verzeroli, Anna Falanga, Barbara Merelli, Carlo Tondini, Marina Marchetti, Mario Mandalà, Eliana Rulli, Francesco De Logu, Romina Nassini, Daniela Massi, Laura Cattaneo

    المساهمون: Falanga, A, Marchetti, M, Massi, D, Merelli, B, Verzeroli, C, Russo, L, Rulli, E, Tondini, C, Legramandi, L, Nassini, R, Scatena, C, De Logu, F, Cattaneo, L, Mandalà, M

    مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, Oncology, medicine.medical_specialty, Skin Neoplasms, Dermatology, 030204 cardiovascular system & hematology, Disease-Free Survival, Fibrin Fibrinogen Degradation Products, 03 medical and health sciences, 0302 clinical medicine, Text mining, Algorithms, Biomarkers, Blood Coagulation, Female, Humans, Melanoma, Mutation, Neoplasm Staging, Prognosis, Protein Kinase Inhibitors, Survival Rate, Thrombophilia, 2708, Internal medicine, medicine, cancer, thrombosis, In patient, metastatic BRAFV600-mutated melanoma BRAF inhibitors, business.industry, Cancer, medicine.disease, Thrombosis, 030220 oncology & carcinogenesis, Cancer research, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3130c5d9a3932a1e68f7deac17ae3dbdTest
    http://hdl.handle.net/11391/1480858Test


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    OC-1a: A prospective study of hemostatic biomarkers to predict early recurrence in high-risk breast cancer women undergoing post-surgical adjuvant systemic therapy.

    المؤلفون: Marchetti, M., Masci, G., Verzeroli, C., Giaccherini, C., Celio, L., Merelli, B., Sarmiento, R., Brevi, S., Gamba, S., Milesi, V., Russo, L., Tartari, C.J., Malighetti, P., Spinelli, D., De Braud, F., Labianca, R., Gasparini, G., Santoro, A., Falanga, A.

    المصدر: Thrombosis Research. Mar2017 Supplement 1, Vol. 151, pS103-S103. 1p.

    مصطلحات موضوعية: *BREAST cancer risk factors, *ADJUVANT treatment of cancer, *CANCER relapse, *HEMOSTASIS, *BIOMARKERS, *LONGITUDINAL method


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث